profit from every $100 of sales.
$0$100
Limoneira
$10.88+2.26% today
-21.7% in 1 year
1-year low $10.061-year high $15.10
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Limoneira sold, what it kept, and what it did with the cash.
Sales went from $185 million in 2022 to $160 million in 2025, with -$16.0 million of profit last year.
SalesProfit
Limoneira vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Limoneira | No profit yet | ||
 Tyson Foods | 44.4× · Expensive | ||
 Bunge Global | 23.8× · Fair price | ||
 Smithfield Foods | 7.8× · Cheap | ||
 Cal-Maine Foods | 2.6× · Cheap |
AI analysis
An AI analyst reads Limoneira's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 185 | 180 | 192 | 160 | |
| 20 | 6 | 21 | 0 | |
| -2 | -20 | -6 | -24 | |
| 12 | 22 | 21 | -10 | |
| -0 | 9 | 8 | -16 | |
| -0.04 | 0.50 | 0.40 | -0.93 | |
| 10.6% | 3.4% | 11.2% | 0.3% | |
| -1.2% | -11.3% | -3.2% | -15.1% | |
| -0.1% | 5.2% | 4.0% | -10.0% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 369 | 301 | 299 | 311 |
| Cash | 1 | 4 | 3 | 2 |
| Total debt | 113 | 45 | 43 | 73 |
| Total liabilities | 177 | 101 | 96 | 120 |
| 180 | 189 | 192 | 172 | |
| 18 | 18 | 18 | 18 | |
| 0.7% | 4.7% | 4.2% | -6.3% | |
| -0.1% | 5.0% | 4.0% | -9.3% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 15 | -16 | 18 | -6 | |
| 10 | 10 | 9 | 14 | |
| 5 | -26 | 8 | -20 | |
| Dividends paid | 6 | 6 | 6 | 6 |
| 0 | – | – | – | |
| 3 | 4 | 4 | 3 |
Valuation
- –
- –
- –
- 1.4×
- 1.2×
- –
- –
- -9.9%
- -8.1%
- 1.8%
Profitability
- 0.3%
- -15.1%
- -10.0%
- -11.0%
- -8.4%
- -0.1%
- -12.8%
- -7.3%
- -10.2%
- –
Growth
- −4.7%
- –
- −327.6%
- +0.0%
- +0.4%
Financial health
- –
- 0.57
- 29.9%
- -14.1×
- 1.16
- 1.16
- 0.47
How it ranks in Consumer Staples
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 2%of 670
Bottom 1%of 674
Bottom 6%of 673
Bottom 2%of 668
What analysts expect
- Average price target
- $21.67
- Range
- $17.00 – $25.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Mar 12, 2026 | -0.48 | -0.33 | −45.5% |
| Sep 9, 2025 | -0.02 | -0.11 | +81.3% |
| Jun 9, 2025 | -0.17 | -0.01 | −1,600.0% |
| Mar 12, 2025 | -0.14 | -0.24 | +41.7% |
| Dec 23, 2024 | -0.09 | -0.07 | −28.6% |
| Sep 9, 2024 | 0.42 | 0.34 | +23.5% |
| Jun 6, 2024 | 0.44 | 0.18 | +144.4% |
| Mar 7, 2024 | -0.18 | -0.27 | +33.3% |
1.8%of the share price, paid each year
On $1,000 invested$18a year at today's yield, before tax
+0.0%2020 to 2025
Raised–not every year
Paid per share, each year
$0.19 in 2015 → $0.30 in 2025
How safe it looks
-24.8% of its profit
Room to growStretchedMore than it earns: -28.2%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
23No pass
Benjamin Graham
42No pass
Philip Fisher
34No pass
Peter Lynch
23No pass
Joel Greenblatt
0No pass
Charlie Munger
26No pass
Terry Smith
26No pass
Questions about Limoneira
Is Limoneira a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Limoneira AI analysis
What does Limoneira do?
Limoneira Company operates as an agribusiness and real estate development company in the United States and internationally. The company operates through three divisions: Agribusiness, Rental Operations, and Real Estate Development. It is in Agricultural Farm Products.
Does Limoneira pay a dividend?
Yes. At today's price the dividend is 1.8% a year. In 2025 it paid out $5.92 million in dividends.
Is Limoneira stock halal?
No. Limoneira does not pass our halal screen: its debt is 37% of its market value, at or above the 33% limit. How we check
How has Limoneira stock done over the past year?
Down 21.7% over the past twelve months, to $10.88. It traded between $10.06 and $15.10 and is 27.9% below its high.
Who are Limoneira's competitors?
The largest listed companies in the same industry are Tyson Foods, Bunge Global, Smithfield Foods and Cal-Maine Foods. The peers table on this page compares their profit, growth and price with Limoneira's.
Prices: daily closes to Nov 9, 2026. Fundamentals: company reports via invest-like data.